Navalign LLC’s Johnson & Johnson JNJ Stock Holding History

Navalign LLC’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-680	Closed	-$141K	–	303
2025 Q4	$141K	Buy	+680	New	+$134K	0.03%	138

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Navalign LLC's JNJ Position: Q1 2026 in Review

Navalign LLC sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 680 shares — an estimated $141K sold.

Navalign LLC first reported a position in JNJ in Q4 2025 and held it in 1 quarter. The position peaked at $141K in Q4 2025. 4,627 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

Navalign LLC reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
Navalign LLC sold 680 Johnson & Johnson shares in Q1 2026, an estimated $141K.
Navalign LLC first reported a position in Johnson & Johnson in Q4 2025 and held it in 1 quarter.
Navalign LLC's Johnson & Johnson position peaked at $141K in Q4 2025.
4,627 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Navalign LLC's 13F filing for Q1 2026, filed 29 Apr 2026.